Data as of Mar 06
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Starpharma Holdings Ltd have a median target of 13.53, with a high estimate of 17.45 and a low estimate of 12.64. The median estimate represents a +112.68% increase from the last price of 6.36.
The current consensus among 3 polled investment analysts is to Outperform stock in Starpharma Holdings Ltd. This rating has held steady since February, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.